Related Experiment Videos
Bone scanning and photon absorptiometry in metabolic bone disease
Bailliere'S Clinical Endocrinology and Metabolism
|February 1, 1988
Summary
Bone scan imaging offers a functional view of skeletal metabolism, aiding in the investigation of bone pathology. Photon absorptiometry measures bone mineral density, valuable for osteoporosis research and diagnosis.
Area of Science:
- Nuclear Medicine
- Radiopharmaceuticals
- Skeletal Imaging
Background:
- Bone scan imaging using technetium-99m labelled diphosphonates visualizes skeletal metabolism.
- Its utility in metastatic disease is well-established, but acceptance in metabolic bone disease is slower.
- The skeleton is challenging to investigate, necessitating familiarity with bone scanning techniques.
Purpose of the Study:
- To highlight the importance of bone scanning in investigating skeletal pathology.
- To discuss the emerging role of photon absorptiometry in bone mineral measurement.
- To evaluate the diagnostic and research potential of these imaging modalities.
Main Methods:
- Bone scan imaging with technetium-99m labelled diphosphonates.
- Photon absorptiometry for bone mineral measurement.
Main Results:
- Bone scanning provides functional display of skeletal metabolism, improving investigation of bone pathology.
- Photon absorptiometry accurately detects and quantifies bone mass changes, valuable for osteoporosis.
- While bone scanning is established, photon absorptiometry's clinical role is still developing.
Conclusions:
- Bone scanning is an essential tool for investigating metabolic bone disorders.
- Photon absorptiometry shows significant potential for osteoporosis diagnosis and management.
- Further research is needed to establish the clinical role of photon absorptiometry.